Clinical Trials
9
Active:0
Completed:2
Trial Phases
5 Phases
Phase 1:1
Phase 2:3
Phase 3:1
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)β’ Click on a phase to view related trials
Phase 2
3 (42.9%)Not Applicable
1 (14.3%)Phase 1
1 (14.3%)Phase 3
1 (14.3%)Phase 4
1 (14.3%)Cortical Excitability in Post-traumatic Epilepsy
Recruiting
- Conditions
- EpilepsyTraumatic Brain InjuryCortical Excitability
- First Posted Date
- 2022-08-26
- Last Posted Date
- 2022-08-26
- Lead Sponsor
- Mid-Atlantic Epilepsy and Sleep Center, LLC
- Target Recruit Count
- 30
- Registration Number
- NCT05517954
- Locations
- πΊπΈ
Mid-Atlantic Epilepsy and Sleep center, Bethesda, Maryland, United States
Prospective Open-label Evaluation of Cenobamate Adjunctive Treatment of Adults With Refractory Focal Epilepsy
- Conditions
- Focal Epilepsy
- First Posted Date
- 2021-05-10
- Last Posted Date
- 2022-08-11
- Lead Sponsor
- Mid-Atlantic Epilepsy and Sleep Center, LLC
- Target Recruit Count
- 100
- Registration Number
- NCT04879433
- Locations
- πΊπΈ
Mid-Atlantic Epilepsy and Sleep Center, Bethesda, Maryland, United States
Treatment of Type 2 Diabetes With Ketogenic Diet
Not Applicable
- Conditions
- ObesityType2 Diabetes Mellitus
- First Posted Date
- 2018-08-29
- Last Posted Date
- 2018-08-29
- Lead Sponsor
- Mid-Atlantic Epilepsy and Sleep Center, LLC
- Target Recruit Count
- 50
- Registration Number
- NCT03652649
- Locations
- πΊπΈ
Ivana Tyrlikova, Bethesda, Maryland, United States
Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.
- First Posted Date
- 2016-04-04
- Last Posted Date
- 2017-08-29
- Lead Sponsor
- Mid-Atlantic Epilepsy and Sleep Center, LLC
- Target Recruit Count
- 8
- Registration Number
- NCT02727101
- Locations
- πΊπΈ
MidAtlantic Epilepsy and Sleep Center, Bethesda, Maryland, United States
Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus
Phase 3
Withdrawn
- Conditions
- Status EpilepticusEpilepsy
- Interventions
- First Posted Date
- 2016-04-04
- Last Posted Date
- 2017-08-29
- Lead Sponsor
- Mid-Atlantic Epilepsy and Sleep Center, LLC
- Registration Number
- NCT02726867
- Locations
- πΊπΈ
MidAtlantic Epilepsy and Sleep Center, Bethesda, Maryland, United States
- Prev
- 1
- 2
- Next
News
No news found